Back to Search
MACK ROACH, M.D.
M.D.
Therapeutic Radiology Physician
NPI: 1770523359IndividualAccepts Medicare
Specialties, Licenses & Credentials
Therapeutic Radiology PhysicianPrimary
Radiology — Therapeutic Radiology
Code: 2085R0203X
00G42845(CA)
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 1979
Research & Publications (20)
Predictive models in external beam radiotherapy for clinically localized prostate cancer.
PMID 19544539·Cancer·2009
6-review
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.
PMID 18172188·J Clin Oncol·2008
3-trial
Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both?
PMID 18167004·Strahlenther Onkol·2007
4-observational
Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial.
PMID 17498886·Int J Radiat Oncol Biol Phys·2007
3-trial
Goserelin acetate in combination with radiotherapy for prostate cancer.
PMID 17257094·Expert Opin Pharmacother·2007
6-review
Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?
PMID 17167758·Cancer·2007
8-other
Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials.
PMID 17084158·J Urol·2006
8-other
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.
PMID 17011443·Int J Radiat Oncol Biol Phys·2006
2-rct
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
PMID 16798415·Int J Radiat Oncol Biol Phys·2006
8-other
Radiotherapy plus adjuvant goserelin improves survival in men with poor prognosis prostate cancer.
PMID 16256275·Cancer Treat Rev·2005
8-other
Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.
PMID 15590164·Int J Radiat Oncol Biol Phys·2004
3-trial
Reducing the toxicity associated with the use of radiotherapy in men with localized prostate cancer.
PMID 15123413·Urol Clin North Am·2004
6-review
Hormonal therapy and radiotherapy for localized prostate cancer: who, where and how long?
PMID 14610408·J Urol·2003
6-review
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413.
PMID 12743142·J Clin Oncol·2003
3-trial
Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate.
PMID 12670556·Urology·2003
4-observational
Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials.
PMID 12478146·J Urol·2003
8-other
Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
PMID 11037558·Radiology·2000
8-other
Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer.
PMID 10875450·Semin Urol Oncol·2000
8-other
Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials.
PMID 10837943·Int J Radiat Oncol Biol Phys·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1600 DIVISADERO STREET, H1031
SAN FRANCISCO, CA 94143 - Phone
- (415) 353-7175
Quick Facts
- NPI
- 1770523359
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile